The novel and selective insulin-like growth factor-1 receptor kinase inhibitor PQIP suppresses bone cell function and osteoclast-breast cancer cell cross-talk in vitro

✍ Scribed by J.G. Logan*; E. Landao-Bassonga; V.G. Brunton; A.I. Idris

• Book ID: 116324043
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 53 KB
• Volume: 48
• Category: Article
• ISSN: 8756-3282
• DOI: 10.1016/j.bone.2010.10.122